Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections

NCT01844856 is registered in ClinicalTrials.gov with Tetraphase Pharmaceuticals, Inc as lead sponsor.

NCT NCT01844856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
Lead sponsor
Tetraphase Pharmaceuticals, Inc
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2013
Completion date
August 31, 2014
Enrollment
541 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

complicated intra-abdominal infections